[go: up one dir, main page]

HK1186666A - Combination treatment for dermatological conditions - Google Patents

Combination treatment for dermatological conditions Download PDF

Info

Publication number
HK1186666A
HK1186666A HK13114151.1A HK13114151A HK1186666A HK 1186666 A HK1186666 A HK 1186666A HK 13114151 A HK13114151 A HK 13114151A HK 1186666 A HK1186666 A HK 1186666A
Authority
HK
Hong Kong
Prior art keywords
pharmaceutically acceptable
dermatological conditions
combination treatment
combination
patient
Prior art date
Application number
HK13114151.1A
Other languages
Chinese (zh)
Inventor
Michael Graeber
Matthew James Leoni
Nathalie Wagner
Original Assignee
Galderma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma S.A. filed Critical Galderma S.A.
Publication of HK1186666A publication Critical patent/HK1186666A/en

Links

Abstract

The invention relates to a method of treating dermatological conditions or symptoms associated therewith in a patient in need thereof by topically administering an effective amount of a combination of brimonidine or a pharmaceutically acceptable salt thereof and oxymetazoline or a pharmaceutically acceptable salt thereof to the affected area of skin on the patient. The invention further relates to topical compositions including the combination of compounds and a pharmaceutically acceptable carrier.
HK13114151.1A 2010-09-28 2011-09-27 Combination treatment for dermatological conditions HK1186666A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61/387,268 2010-09-28
US13/232,139 2011-09-14

Publications (1)

Publication Number Publication Date
HK1186666A true HK1186666A (en) 2014-03-21

Family

ID=

Similar Documents

Publication Publication Date Title
WO2012050831A3 (en) Combination treatment for dermatological conditions
WO2012047645A3 (en) Combination treatment for rosacea
MX369385B (en) Products for healing of tissue wounds.
HK1198869A1 (en) Combination treatments for hepatitis c
BR112015012312A2 (en) method of treatment, risk reduction, prevention or alleviation of a condition or lung disease in a subject; method of reducing or suppressing lung inflammation in a subject; and method of promoting pulmonary repair in a subject
WO2010107807A3 (en) Compounds for treating inflammation and pain
EA201270570A1 (en) COMBINED THERAPY OF CANCER DISEASES USING HSP90 INHIBITOR COMPOUNDS
WO2011117377A3 (en) Compositions comprising brimonidine for the treatment of erythema
WO2009109613A3 (en) 1-BENZYL-3-HYDROXYMETHYLINDAZOIιE DERIVATIVES AND USE THEREOF IN THE TREATMENT OF DISEASES BASED ON THE EXPRESSION OF MCP-1, CX3CR1
WO2013100567A8 (en) Phenyl carbamate compounds for use in alleviating or treating pain and neuropathic pain
HK1202448A1 (en) Topical formulation for administering a compound
WO2009109616A3 (en) 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cxrl and p40
WO2011117378A3 (en) Compositions comprising brimonidine for the treatment of erythema
NZ586302A (en) Pre-surgical treatment using brimonidine applied topically to reduce bleeding or bruising
WO2009109654A8 (en) 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, and cx3cr1
WO2010098600A3 (en) Substituted azole derivatives, pharmaceutical composition containing the derivatives, and method for treating parkinson's disease using the same
NZ594184A (en) Skin treatment
EA201401031A1 (en) A HALF-LEVELED COMPOSITION FOR LOCAL APPLICATION THAT CONTAINS Pyrphenidone and Modified Diallyldisulfide Oxide (M-DDO) to Remove or Prevent Ugrey
WO2009041663A1 (en) Agent for prevention and/or treatment of skin diseases
WO2012012305A3 (en) Combination therapy using a ruthenium complex
WO2012103282A3 (en) Methods and compositions for treating alzheimer's disease
WO2014047288A3 (en) Transglutaminase tg2 inhibitors, pharmaceutical compositions, and methods of use thereof
MY182553A (en) Pharmaceutical compositions comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions
MX366309B (en) Pharmaceutical composition for treating inflammation and pain.
WO2014015137A3 (en) Compositions and methods for treating dysproliferative diseases